Provider of technology and services to the global offshore energy markets
We provide Investor Relations and Communications services to Tekmar Group PLC. Tekmar Group PLC are listed on the London Stock Exchange PLC.
We are retained by Medical Incubator Japan (“MIJ”), a Japanese investment fund to help identify investment opportunities in the UK and Europe and provide research support. MIJ is focused on the areas of Pharmaceutical, Medical Devices and Digital Health.
Provider of services to remote locations
We are retained by RA International to provide Investor Relations and Communications services. RA International are listed on the London Stock Exchange PLC.
Welfare Accommodation Supplier
We advised the shareholders of Advanté on the sale of the business to Modulaire Group following a successful dual track process to find a buyer. This was the conclusion of a multi-year relationship working with the shareholders and management and resulted in a very successful outcome for all parties.
Independent provider of elective surgery services to the NHS
We advised the Pioneer Healthcare team on the sale of the business to Totally PLC. This successful process resulted in the right partnership to drive expansion and strategic growth.
We provided corporate finance and strategic advice to Mudano for several years culminating in a process to explore options to support the next phase of growth for Mudano. This process resulted in an acquisition by Accenture from their Applied Intelligence division.
Temperature-controlled biological sample storage and logistics services
We helped biological sample storage company, Cryoniss, raise funding from the Northern Powerhouse Investment Fund – Maven Equity Finance and two prominent HNW investors. This successful outcome will assist Cryoniss in their plans to expand the business.
RWE Data and Clinical Trials
We were retained by the shareholders of NWEH to provide strategic & management support during a period of change.
We advised the management and founder shareholders of a management consultancy and technology business on its sale to a leading UK private equity firm. The business had grown rapidly in recent years and the transaction provided an exit for initial founder investor shareholders, a partial exit for management, and the opportunity to realign the shareholder base for the next phase of growth.
We helped specialist build to rent provider Rise Homes Limited raise equity funding from private equity firm Gresham House. When combined with senior debt, this enabled Rise to develop two initial schemes in the North West of England as part of its goal to create a leading a provider of high-quality PRS accommodation aimed at the mass market.
Contract Research and Development Services
We helped management negotiate an acquisition of Epistem from Genedrive PLC, establish a growth plan and then raised £2m of funding from Foresight Group to fund the consideration and provide development capital.
We acted for management on the sale of Baywater Healthcare to the Bastide Group based in France. Management had acquired the business with the help of Duke Street Investments and Souter Investments two years previously.
Financial Service and Retailer
We acted for the shareholders (NorthEdge and Management) on the IPO of Ramsdens Holdings PLC, raising £15.6m. A year later we acted again for NorthEdge on a subsequent placing of their residual shareholding, raising a further £15.6m.
We helped establish a UK company and raised £1.25m to fund the acquisition of IP and provide growth capital to develop and commercialise antimicrobial technology SILVERbac.
Credit Management Services
We acted for the founders of Orbit Debt Collections Limited at a time of significant growth to help them explore strategic options for the business. This resulted in a sale of the business to the Cabot Financial Group which provided a structured exit for shareholders plus support and investment for further growth.
Contract Research Services
We acted for the shareholders of Peakdale Molecular Limited when strategic options were being considered. This resulted in a sale of the business to Concept Life Sciences, backed by Equistone which was one of three transactions valued at $100m in total.
We acted for the founder of Neudrive in acquiring IP from the Centre for Process Innovation and raising funds.
We advised on the IPO of Concepta following the previous fundraise.
We acted for NorthEdge when they provided acquisition and development funding for Direct Healthcare Services. We provided commercial and strategic advice.
We helped Concepta secure £2.5m of investment from a combination of High Net Worth individuals, the Angel Co Investment fund and Mercia.
Children's Toy Developer
We acted for the majority shareholder of Casdon plc to raise debt funding to acquire the other minority shareholdings and undertake a Takeover Code compliant Recommended Offer.
Pharmaceutical Storage Solutions
We acted as the Rule 3 Adviser on the £12m Takeover Code compliant Recommended Offer of Vindon Healthcare plc by Source Bioscience plc.
We were co-founders of Collagen Solutions helping the CEO acquire a clean room facility based in Glasgow out of Administration. We raised funds from High Net Worth individuals and 12 months later arranged an IPO and advised on 2 pivotal acquisitions, one in the US and one in New Zealand.
Financial Investment Company
We acted on behalf of companies within the investment portfolio of John Laithwaite Partners to provide M&A services as well as strategic CFO support.
Paediatric Medicines Developer
We acted for the founders of Proveca Limited to help create their business plan and then raise £2.6m from Albion Ventures. We continue to be a retained advisor to Proveca.
We acted for Horizon Discovery in assisting in a pre-IPO bridging fundraise.
Health Informatic Services
We acted for the founders of Harvey Walsh Limited on the sale of the business to Open Health (part of Chime Communications plc).
DNA Testing Labratory Services
We acquired a non-core asset from a larger private business working with Nick Ash & Nick Leaves, both highly regarded and successful businessmen who previously built Source Bioscience. Investment support was provided from a prominent North West HNW.
17 Marble Street,
+44 (0)161 240 7550
The Core, Bath Lane,
Newcastle Upon Tyne
+44 (0)191 249 7441
2 Walker Street,
+44 (0)131 376 0901
© 2019 Bamburgh Capital Limited. All Rights Reserved. Registered in England and Wales No. 07155076. Registered Office: Bloc, 17 Marble Street, Manchester M2 3AW. Bamburgh Capital Limited is regulated and authorised by the Financial Conduct Authority.